Company / Free Cash Flow
Mirum Pharmaceuticals, Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$54.9M
FY2025
5-year range
-$132.8M / $54.9M
FY2021-FY2025
Trend
+488.0%
vs FY2024
Sector context
#51 of 194
Health Care
What the data says
Free Cash Flow changed +488% YoY in FY2025, a notable deviation from the 7-year average annual change of -1436%.
Based on SEC 10-K filings.
$55M in FY2025.
Improved from -$71M to $55M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#51 of 194 in Health CareTop 26% of 194This company $54.9M Sector average $470.8M
▼
-88.3% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 488.0% year-over-year.
- Ranks #51 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.9M | +488.0% |
| FY2024 | $9.3M | +113.1% |
| FY2023 | -$71.1M | +46.5% |
| FY2022 | -$132.8M | -48.7% |
| FY2021 | -$89.3M | +0.0% |
| FY2020 | -$89.3M | -125.3% |
| FY2019 | -$39.6M | -10528.2% |
| FY2018 | -$373.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026